Literature DB >> 12740672

Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.

Y Baykal1, K Saglam, M I Yilmaz, A Taslipinar, S B Akinci, A Inal.   

Abstract

In this study we investigated cytokine levels in patients with familial Mediterranean fever (FMF). Twenty patients and 20 healthy controls were included. Ten patients had acute attacks of FMF, whereas the other 10 were in the silent period. Patients with the acute exacerbation of FMF had higher soluble interleukin-2 receptor (sIL-2r), interleukin-6 (IL-6), tumour necrosis factor-alpha, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and fibrinogen levels than those in the silent period ( P<0.001) and controls ( P<0.001). In patients with acute attacks of FMF, interleukin-10 (IL-10) levels were not significantly different from those in the other patients or the controls ( P>0.05). In FMF patients IL-6, TNF-alpha, sIL-2r, ESR, CRP and fibrinogen levels increased with the acute-phase reaction, especially in the attack period. On the other hand, anti-inflammatory cytokine IL-10 levels did not increase as much as did the inflammatory cytokines. The balance between the cytokines may help us to understand the pathophysiology of FMF and to develop therapies. We conclude that the levels of the acute-phase reactants and the cytokines could be useful for diagnosis of acute exacerbations, follow-up and treatment. However, the cost of cytokine measurement analyses seems disadvantageous at present.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740672     DOI: 10.1007/s10067-002-0682-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Authors:  Eren Erken; Huseyin T E Ozer; Ramazan Gunesacar
Journal:  Rheumatol Int       Date:  2006-01-06       Impact factor: 2.631

2.  Is there a hypothalamic-pituitary-adrenal axis dysfunction in patients with familial Mediterranean fever?

Authors:  Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

3.  Is there a real adrenal axis dysfunction in patients with amyloidosis associated with familial Mediterranean fever?

Authors:  Guven Yılmaz; Seval Masatlioglu; Demet Ozgil Yetkin; Refik Demirtunç; Serife Nur Boysan; Semiha Kaplan; Nurhan Ince
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

4.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

Review 5.  A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

Authors:  Andrea Rubbert-Roth; Daniel E Furst; Jan Michael Nebesky; Angela Jin; Erhan Berber
Journal:  Rheumatol Ther       Date:  2018-03-03

6.  Evaluation of the mean platelet volume in children with familial Mediterranean fever.

Authors:  Seçil Arıca; Cahit Ozer; Vefik Arıca; Ali Karakuş; Tanju Celik; Ramazan Güneşaçar
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

7.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

8.  Bone mineral density in patients with familial Mediterranean fever.

Authors:  Kadir Yildirim; Saliha Karatay; Ramazan Cetinkaya; Hulya Uzkeser; Akin Erdal; Ilyas Capoglu; Fazile Hatipoglu Erdem
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

9.  Mean platelet volume in children with familial Mediterranean fever.

Authors:  Balahan Makay; Zeynep Türkyilmaz; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

10.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.